Updated clinical data and biological correlative analyses of ciltacabtagene autoleucel (ciltacel) in lenalidomide-refractory multiple myeloma after 1-3 prior lines of therapy: CARTITUDE-2 Cohort A
Clinical Lymphoma Myeloma and Leukemia(2022)
关键词
multiple myeloma,ciltacabtagene autoleucel,cilta-cel,lenalidomide-refractory
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要